Article
Gene therapy for Parkinson's disease
1 Jan 2010
Abstract excerpt
The once fantastic theoretical concept that patients with Parkinson's disease (PD) would receive gene therapy in an attempt to alleviate their symptoms and potentially modify the course of their disease has become a reality. On the basis of positive preclinical data, four different gene therapy approaches are currently in Phase I or Phase II clinical trials. Some approaches are intended to increase levels of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
